Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Adaptive Phage Therapeutics, Inc.
*MAILING ADDRESS
708 Quince Orchard Road, Suite 205
*CITY
Gaithersburg
*STATE
(Required for U.S. applicants)
Maryland
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
20878
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
001
*IDENTIFICATION
diagnostic reagents for clinical and medical laboratory use; diagnostic kits comprised of reagents for testing for bacteria sensitivity
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
005
*IDENTIFICATION
diagnostic kits comprised of medical diagnostic reagents for testing for bacteria sensitivity
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
042
*IDENTIFICATION
providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of bacterial infections, and the
analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; laboratory
research in the field of genomic sequencing; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of bacteria
and viruses; laboratory research in the field of infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services; microbiological laboratory testing of
bacteria for research purposes, and technical consultation thereto; scientific and medical research, in particular design and development of diagnostic assays
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
044
*IDENTIFICATION
providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of bacteria infections, and the analysis,
evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments
accordingly; medical services; consulting services in the field of medical diagnostic and prognostic testing; medical analysis services for diagnostic and prognostic testing and treatment purposes;
providing medical diagnostic and prognostic testing services; medical analysis services relating to the diagnosis and treatment of person; microbiological laboratory testing of bacteria for
diagnostic and medical purposes, and technical consultation thereto; medical testing and diagnostic services for diagnostic or treatment purposes, in particular performing tests using diagnostic
assays
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:97074042
Filing Date:10/14/2021
To the Commissioner for Trademarks:
MARK: PHAGEBANK SUSCEPTIBILITY TEST (Standard Characters, see mark)
The literal element of the mark consists of PHAGEBANK SUSCEPTIBILITY TEST. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Adaptive Phage Therapeutics, Inc., a corporation of Delaware, having an address of
708 Quince Orchard Road, Suite 205
Gaithersburg, Maryland 20878
United States
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 001: diagnostic reagents for clinical and medical laboratory use; diagnostic kits comprised of reagents for testing for bacteria sensitivity
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 005: diagnostic kits comprised of medical diagnostic reagents for testing for bacteria sensitivity
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 042: providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of bacterial infections, and the analysis, evaluation, and
reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; laboratory research in the field of
genomic sequencing; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of bacteria and viruses; laboratory
research in the field of infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services; microbiological laboratory testing of bacteria for research
purposes, and technical consultation thereto; scientific and medical research, in particular design and development of diagnostic assays
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 044: providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of bacteria infections, and the analysis, evaluation, and reporting of
those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services;
consulting services in the field of medical diagnostic and prognostic testing; medical analysis services for diagnostic and prognostic testing and treatment purposes; providing medical diagnostic and
prognostic testing services; medical analysis services relating to the diagnosis and treatment of person; microbiological laboratory testing of bacteria for diagnostic and medical purposes, and
technical consultation thereto; medical testing and diagnostic services for diagnostic or treatment purposes, in particular performing tests using diagnostic assays
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The owner's/holder's proposed attorney information: Stacey J. Watson, Esq.. Other appointed attorneys are Katrina G. Hull, Jacqueline L. Patt. Stacey J. Watson, Esq. of Markery Law LLC, is a
member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
P.O. Box 84150
Gaithersburg, Maryland 20883-4150
United States
202-888-7786(phone)
(202) 803-7953(fax)
docket@markerylaw.com
The docket/reference number is US-PHGE-008A.
Stacey J. Watson, Esq. submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any
U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1400 has been submitted with the application, representing payment for 4 class(es).
Declaration
Declaration Signature
Signature: /Michele Wales/ Date: 10/14/2021
Signatory's Name: Michele Wales
Signatory's Position: Attorney
Signatory's Phone Number: 3016751732
Signature method: Sent to third party for signature
Payment Sale Number: 97074042
Payment Accounting Date: 10/14/2021
Serial Number: 97074042
Internet Transmission Date: Thu Oct 14 10:20:14 ET 2021
TEAS Stamp: USPTO/BAS-XXXX:XXXX:XXXX:XXXX:XXXX:XXXX:
XXXX:XXXX-20211014102014948090-97074042-
781e3153b3762351bf0d288475c468a5ddea75fc
2de55fbe205b956dd1b57dbbb-CC-20131715-20
211008103937079600